24
Participants
Start Date
January 4, 2023
Primary Completion Date
June 26, 2023
Study Completion Date
June 28, 2023
3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fed condition
a single dose of 1 mg AEF0117 in fed condition
3ß-(4-methoxybenzyloxy)pregn-5-en-20-one in fasting condition
a single dose of 1 mg AEF0117 in fasting condition
Substance Use Research Center, New York
Lead Sponsor
National Institute on Drug Abuse (NIDA)
NIH
Aelis Farma
INDUSTRY